Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres

Elaine Cristina Francisco(Universidade Federal do Paraná), Arnaldo Lopes Colombo(Universidade Federal de São Paulo), Rosane Christine Hahn(Universidade Federal de Mato Grosso), Thaís Guimarães(Hospital do Servidor Público Estadual), Ana Carolina Barbosa Padovan(Universidade Federal de Alfenas), Paulo de Tarso Oliveira e Castro(Hospital de Câncer de Barretos), Valério Rodrigues Aquino(Universidade Federal do Rio Grande do Sul), Guilherme Maranhão Chaves(Universidade Federal do Rio Grande do Norte), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Maria Goreth Barberino(Hospital São Rafael), Flávio de Queiroz Telles(Universidade Federal do Paraná), João Nóbrega de Almeida(Universidade Federal de São Paulo)
Clinical Microbiology and Infection
April 13, 2019
10.1016/j.cmi.2019.03.026
Cited by 79

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Simultaneous Emergence of Multidrug-Resistant <i>Candida auris</i> on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
|Clinical Infectious Diseases|2016|1.6k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
|The Lancet|2022|467